The Hutch closes in on a cancer cure

The Seattle Times | 5/17/2018 | Ron Judd
JimmyJoe (Posted by) Level 3
Click For Photo: https://static.seattletimes.com/wp-content/uploads/2018/05/HutchCellLabFULL_takeoverNEW-1200x630.jpg

THE MAGIC MICROSCOPIC particles that might change the world — and in the process, permanently burnish Seattle’s spot on the big, ascent-of-man scientific map — are, at this very moment, being carted about on a medical campus one short traffic jam away from the shores of Lake Union. Their mode of transport: a thermo-molded plastic lunch cooler, of the sort one might nab at Walmart to carry a baloney sandwich and some freshly cured herring out for a day of salmon fishing on Puget Sound.

The little coolers are ubiquitous at the Fred Hutchinson Cancer Research Center, which four decades ago pioneered a groundbreaking treatment for blood cancers — the bone-marrow transplant, now an older science that still saves lives, but not without harrowing side effects.

Cancer - Research - Almost - Everything - Research

What has changed in cancer research since then? Almost everything. But the research growing from those transplants is blossoming today into what could be, at last, actual cures for common cancers that have long stood as irrevocable death sentences for millions of people.

Some of the new treatments — collectively, “immunotherapies” that unleash the body’s own immune system to seek out and destroy cancer cells — have shown mind-blowing results in early testing on blood cancers.

Trial - Patients - Leukemia - Treatments - Remission

In one ongoing trial, patients with a leukemia that had resisted previously known treatments achieved a remission rate of 93 percent — a result that even seasoned researchers at The Hutch called “astounding,” particularly given the treatment’s relative lack of the destructive side effects of traditional radiation and chemotherapy. The weapon of choice — re-engineered human “CAR-T” cells — did its work more efficiently and completely than even its creators had dared dream.

During that trial, the oncologist for one terminally ill patient phoned a veteran Fred Hutchinson researcher, Dr. Stanley Riddell, less than a week after the administration of a single dose...
(Excerpt) Read more at: The Seattle Times
Wake Up To Breaking News!
Tagged:
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!